Orchestra BioMed Holdings Inc <OBIO.O>: BTIG raises to Buy from Neutral
OBIO•Related News
Adial Pharmaceuticals appoints David Rubenstein as chief scientist
ADIL•
Verastem raises target price to $14 from $13
VSTM•
Applied Materials: Needham cuts target price to $580 from $740
AMAT•
Rentokil Initial partners with Debug to expand mosquito control across Europe
RTO•
Faeth Therapeutics, Inc: William Blair initiates coverage with outperform rating
FTH•